The punitive damages phase of the Atlantic City Vioxx trial continued Monday, when the jury that last week found Merck & Co. liable for not properly warning of the dangers its drug posed to plaintiffs with heart problems began deliberation over whether the company should pay additional damages.

After a five-week trial and 14 hours of deliberation, the jury awarded $3 million on April 5 to John McDarby, 77, who suffered a heart attack in 2004 after four years of Vioxx use, and $1.5 million to his wife Irma. The panel denied damages to co-plaintiff Thomas Cona, 60, who had a heart attack in 2003 but could produce only three prescriptions for the preceding two years he claimed to have taken Vioxx.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]